Live catalyst feed

Wednesday, September 30, 2026

Every market-moving event Day Trader Sniper classified this session, with HCS category, session chart, and observed market response. Not financial advice.

←→Jump to latest

Regulatory and ClinicalPositive Topline ResultsSep 30, 2026 · 7:03am ET

CNTBConnect Biopharma Holdings Ltd

Connect Biopharma Announces Positive Preliminary Topline Data from Global Phase 2 Study of Rademikibart

The study focused on Rademikibart as an add-on treatment for acute exacerbations in adults with COPD and Type 2 inflammation.

Regulatory and ClinicalPositive Topline ResultsSep 30, 2026 · 7:03am ET

CNTBConnect Biopharma Holdings Ltd+102.4%

Connect Biopharma Announces Positive Preliminary Topline Data from Global Phase 2 Study of Rademikibart

Be early on the next spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →